Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi +3 more
wiley +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
Drug-eluting balloon as an alternative to stenting in a severely calcified right coronary artery after multimodal plaque modification. [PDF]
Priadka A +5 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
Minimally Invasive Coronary Artery Bypass With Composite Arterial Graft for High-Bifurcation Anomalous Aortic Origin of Right Coronary Artery. [PDF]
Kurien GV +4 more
europepmc +1 more source
Ostial right coronary artery stent loss, stent-in-stent entrapment, and subsequent surgical extraction. [PDF]
Saleem D +3 more
europepmc +1 more source
A unique finding of concomitant aneurysms of the right sinus of Valsalva and the right coronary artery treated conservatively. [PDF]
Horosin G +7 more
europepmc +1 more source
"Resect & respect" surgical approach for anomalous right coronary artery aneurysm originating from the pulmonary artery. [PDF]
Yang B +3 more
europepmc +1 more source
Use of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia. [PDF]
Michael R, Somaratne J, Eaddy N.
europepmc +1 more source
Related searches:

